返回 Agenda
Session 4A: (Parallel Session) Supporting Innovation - Pharm & Bio
Session Chair(s)
Mei Ding
JAPAC Regional Lead, Policy & Intelligence
Abbvie Pte. Ltd., Singapore
Speaker(s)
Support to Quality Development in Early Access Approaches
Marta Parmar
Biogen (Singapore) Pte Ltd, Singapore
Assoc. Director- Regulatory Affairs CMC GEM AsiaPac
Next Generation Antibody Drug Conjugates
Steve Davidsen
Abbvie, Singapore
Vice President
Virus Specific T Cells as Platform for Solid Tumor Immunotherapy
Richard Hopkins
Tessa Therapeutics Pte Ltd, Singapore
Research Director, R&D
Drive Botanical Drugs to Work-class Development
May Wei
Moleac Pte Ltd, Singapore
VP, Regulatory Affairs
Liposome for targeting and sustained release in clinical use
Yun-Long Tseng
Taiwan liposomal Companies, Taiwan
Vice President